1/41
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Absorption Interactions
Alterations in GI solubility, transit time, or active efflux transporters reduce or accelerate bioavailability.
Gastric pH Alteration
Chelation & Complexation
GI Motility Shifts
P-Glycoprotein (P-gp) Inhibition
Gastric pH Alteration
Weakly acidic drugs require an acidic gastric pH to remain non-ionized and soluble for absorption. Antacids, H2 blockers, and PPIs raise pH, stopping dissolution.
Chelation & Complexation
Polyvalent cations bind drugs, forming an insoluble ring structure that cannot cross the intestinal wall.
P-Glycoprotein (P-gp) Inhibition
Prokinetic agents speed gastric emptying (delivering drugs to the small intestine faster); anticholinergics slow transit time
P-Glycoprotein (P-gp) Inhibition
P-gp is an efflux pump in intestinal enterocytes that pumps drugs back into the lumen. Inhibiting P-gp dramatically increases oral absorption.
Gastric pH Alteration: example
Omeprazole + Ketoconazole / Itraconazole
Result: Decreased antifungal absorption and treatment failure.
Chelation & Complexation: Example
Antacids / Milk + Tetracyclines or Ciprofloxacin
Result: Over 80% reduction in antibiotic absorption.
GI Motility Shifts: Example
Metoclopramide + Acetaminophen (accelerates absorption) vs. Atropine + Morphine (delays absorption).
P-Glycoprotein (P-gp) Inhibition: Example
Verapamil / Amiodarone / Clarithromycin + Digoxin
Result: Increased Digoxin absorption → Digoxin Toxicity.
Plasma Protein Displacement
Only unbound (free) drug is pharmacologically active and capable of causing toxicity. Displacing 1–2% of a highly bound drug can double its active free concentration.
Kernicterus
Other Displacements: Sulfonamides displace Bilirubin from albumin in neonates → ‘blank’ (encephalopathy).
Excretion Interactions
Occur primarily in the renal tubules through competition for active secretion transporters or alteration of urinary pH.
Renal Tubular Competition
Renal Hemodynamics & Lithium Toxicity
Urinary Ion Trapping
Renal Tubular Competition
Probenecid blocks the Organic Anion Transporter (OAT) in the proximal tubule.
Application: Given with Penicillin to prolong penicillin's half-life; causes toxicity when co-administered with Methotrexate.
Renal Hemodynamics & Lithium Toxicity
Lithium is handled like Sodium in the proximal tubule.
Sodium depletion
Thiazide Diuretics, NSAIDs, or ACE inhibitors cause ‘blank’ → proximal tubule reabsorbs more Sodium AND Lithium → Severe Lithium Toxicity (tremors, ataxia, seizures)
Alkalinization (Sodium Bicarbonate)
Ionizes weak acids (Aspirin, Phenobarbital), forcing clearance during overdose
Acidification (Ammonium Chloride / Ascorbic Acid)
Ionizes weak bases (Amphetamines, Quinidine), driving urinary elimination.
Benzodiazepines + Alcohol / Opioids: interaction type, Dangerous clinical outcome
Interaction Type: Additive GABAa/ Mu-receptor CNS depression
Dangerous Clinical Outcome: Severe respiratory depression, coma, death
Sildenafil + Nitroglycerin: interaction type, Dangerous clinical outcome
Interaction Type: Synergistic cGMP accumulation
Dangerous Clinical Outcome: Precipitous drop in blood pressure → Severe shock/MI.
ACE Inhibitor + Spironolactone: interaction type, Dangerous clinical outcome
Interaction Type: Additive Potassium retention
Dangerous Clinical Outcome: Life-threatening Hyperkalemia → Cardiac arrest.
Aminoglycoside + Furosemide: interaction type, Dangerous clinical outcome
Interaction Type: Additive Ototoxicity & Nephrotoxicity
Dangerous Clinical Outcome: Permanent deafness and acute tubular necrosis
MAO Inhibitor + SSRI / Meperidine: interaction type, Dangerous clinical outcome
Interaction Type: Excessive Synaptic Serotonin accumulation
Dangerous Clinical Outcome: Serotonin Syndrome (hyperthermia, rigidity, myoclonus).
Propranolol + Salbutamol: Interaction mechanism, Clinical consequence
Interaction Mechanism: Non-selective B-blocker competes with B2-agonist
Clinical Consequence: Severe bronchospasm in asthmatic patients.
Morphine + Naloxone: Interaction mechanism, Clinical consequence
Interaction Mechanism: Competitive antagonism at mu-opioid receptors
Clinical Consequence: Instant reversal of analgesia and opioid respiratory depression.
NSAIDs + Antihypertensives: Interaction mechanism, Clinical consequence
Interaction Mechanism: NSAIDs block renal prostaglandin synthesis (PGE2/ PGI2)
Clinical Consequence: Sodium/water retention that blunts the efficacy of ACEi, Diuretics, and B-blockers
Warfarin + Vitamin K: Interaction mechanism, Clinical consequence
Interaction Mechanism: Vitamin K bypasses Warfarin's blockade of VKORC1
Clinical Consequence: Complete loss of Warfarin anticoagulation (clot risk)
Tyramine-Rich Foods + MAO Inhibitors (Phenelzine, Tranylcypromine)
Hypertensive Crisis ("Cheese Effect" — triggered by aged cheese, red wine, cured meats).
Grapefruit Juice + Calcium Channel Blockers / Statins
Inhibits intestinal CYP3A4, increasing oral bioavailability by 200- 400%
St. John’s Wort + Cyclosporine / Digoxin / Warfarin
CYP3A4 and P-glycoprotein, causing organ transplant rejection (Cyclosporine failure) or loss of anticoagulation
Ginkgo Biloba / Garlic / Ginseng + Anticoagulants
Antiplatelet properties that additively increase bleeding risks without altering INR values
Digoxin + Amiodarone
Primary Mechanism: P-gp Inhibition & Reduced Clearance
PHLE board exam result: Digoxin Toxicity (Yellow-green halos, arrhythmias).
Lithium + Hydrochlorothiazide
Primary Mechanism: Reduced Renal Clearance via Na+ Depletion
PHLE board exam result: Lithium Toxicity (Ataxia, coarse tremors).
Warfarin + Trimethoprim-Sulfa
Primary Mechanism: CYP2C9 Inhibition & Protein Displacement
PHLE board exam result: Severe Bleeding / Soaring INR.
Methotrexate + NSAIDs
Primary Mechanism: Inhibition of Renal Transporters (OAT)
PHLE board exam result: Bone Marrow Suppression (Pancytopenia)
Terfenadine / Cisapride + Ketoconazole
Primary Mechanism: PCYP3A4 Inhibition leading to accumulation
PHLE board exam result: Torsades de Pointes (Fatal QT prolongation)
Metformin + Radiocontrast Dye
Primary Mechanism: Contrast-induced Acute Kidney Injury
PHLE board exam result: Severe Lactic Acidosis.
Check the Enzyme Type
If an item mentions Rifampicin, Phenytoin, or Carbamazepine, look for an answer describing decreased drug efficacy or treatment failure
Check the Elimination Path
If an item involves Lithium, Digoxin, or Methotrexate, look for a second drug that impairs renal clearance (Diuretics, NSAIDs, Transporter Inhibitors).
Differentiate Bleeding Mechanics
Warfarin + Enzyme Inhibitor (e.g., Metronidazole)
Warfarin + Aspirin/NSAID
Warfarin + Enzyme Inhibitor (e.g., Metronidazole)
Increases INR and causes bleeding.
Warfarin + Aspirin/NSAID
Increases bleeding risk via direct antiplatelet/ulcerogenic effects without changing the INR value.